Autres langues PDS Biotechnology Corporation

Actions

PDSB

US70465T1079

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/05/2024			Varia. 5j.	Varia. 1 janv.
2,98 ^USD	+1,02 %		-3,25 %	-40,04 %

15/05	PDS Biotechnology Corporation annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
10/05	NetScientific déclare que Versamune de PDS Biotech répond aux critères d'évaluation	AN

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
NetScientific says PDS Biotech's Versamune meets endpoints	10/05
PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study	10/05
PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer	09/05
Transcript : PDS Biotechnology Corporation - Special Call	08/05
PDS Biotechnology Corporation Appoints Stephan Toutain as Chief Operating Officer	02/05
PDS BIOTECHNOLOGY CORPORATION : B. Riley toujours à l'achat	28/03
Empire Metals targets key milestones in Australia	27/03
Transcript : PDS Biotechnology Corporation, 2023 Earnings Call, Mar 27, 2024	27/03
PDS Biotechnology Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
PDS Biotechnology Corporation Announces Publication of Preclinical Research	13/03
PDS Biotechnology Corporation Announces Executive Changes	22/01
Apyx Medical Names Matthew Hill as CFO	28/11
PDS Biotechnology Appoints Lars Boesgaard as Finance Chief	28/11
PDS Biotechnology Corporation Announces Resignation of Matthew Hill as Principal Financial Officer and Principal Accounting Officer, Effective December 1, 2023	28/11
PDS BIOTECHNOLOGY CORPORATION : Oppenheimer persiste à l'achat	15/11
Transcript : PDS Biotechnology Corporation, Q3 2023 Earnings Call, Nov 14, 2023	14/11
PDS Biotechnology Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
NetScientific's portfolio company updates on cancer trial	09/11
PDS Biotech Announces Updated Survival Data from NCI-Led Phase 2 Clinical Trial of Pds0101-Based Triple Combination Therapy in Advanced Hpv16-Positive Cancer Patients	09/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues PDS Biotechnology Corporation

Actions

PDSB

US70465T1079

Autres langues

Filtres